ArticleMaterials (Basel, Switzerland)2021
Thermoplastic Intumescent Coatings Modified with Pentaerythritol-Occluded Carbon Nanotubes.
Article in Materials (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 3 citations in OpenAlex.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A thermoplastic intumescent coating system (IC) based on poly(vinyl acetate) was modified by two forms of multiwalled carbon nanotubes (CNTs), i.e., by a nanofiller powder and its solid dispersions in pentaerythritol (PER-CNTs). It was revealed that only the PER-CNTs modifier allows us to obtain solvent-borne ICs with a relatively high CNTs concentration (1-3 wt. parts of CNTs/100 wt. parts of paint solids) and acceptable application viscosity. Thermal insulation time (TIT) and intumescent factor (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.